Literature DB >> 11722642

Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern.

H Höhn1, C Kortsik, K Nilges, A Necker, K Freitag, G Tully, C Neukirch, M J Maeurer.   

Abstract

CD8+ T cells can be grouped into two different types of secretory T lymphocytes, based on the cytokine-secretion pattern upon antigen exposure: those with a T-cell cytotoxic type 1 response (Tc1), which secrete interferon-gamma (IFN-gamma), or those with a T-cell cytotoxic type 2 response, which secrete interleukin (IL)-4 and IL-10. We examined the CD8+ T-cell response directed against an immunodominant human leucocyte antigen (HLA)-A2-presented peptide derived from a 19-kDa Mycobacterium tuberculosis-associated antigen. T cells were examined by functional analysis and by T-cell receptor (TCR) complementarity-determining region 3 (CDR3)-spectratyping, which defines the complexity of a T-cell response. T-cell stimulation with the immunodominant VLTDGNPPEV epitope yielded a Tc2 (IL-4) cytokine-secretion pattern and resulted in oligoclonal expansion of TCR-variable beta chain (VB) families, which differed from patient to patient. Generation of T-cell clones corroborated the notion that the CD8+ T-cell response directed against the HLA-A2-presented VLTDGNPPEV epitope leads to a Tc2 cytokine-secretion pattern in CD8+ T cells, as defined by IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) release. Characterization of the cytokine-secretion profile in HLA-A2/VLTDGNPPEV-tetramer sorted T cells from patients with active tuberculosis supported this observation: peptide-specific T cells from three of three patients secreted IL-4 and only one of three patients produced IFN-gamma in response to the nominal target epitope. Permutation of this T-cell epitope may aid to elicit a qualitatively different CD8+ T-cell response in patients with M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722642      PMCID: PMC1783313          DOI: 10.1046/j.1365-2567.2001.01307.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding.

Authors:  M Bodinier; M A Peyrat; C Tournay; F Davodeau; F Romagne; M Bonneville; F Lang
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  On the dynamics of TCR:CD3 complex cell surface expression and downmodulation.

Authors:  H Liu; M Rhodes; D L Wiest; D A Vignali
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

3.  Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction.

Authors:  D M Lewinsohn; A L Briden; S G Reed; K H Grabstein; M R Alderson
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides.

Authors:  E Jäger; M Maeurer; H Höhn; J Karbach; D Jäger; Z Zidianakis; A Bakhshandeh-Bath; J Orth; C Neukirch; A Necker; T E Reichert; A Knuth
Journal:  Int J Cancer       Date:  2000-05-15       Impact factor: 7.396

5.  The 19-kD antigen and protective immunity in a murine model of tuberculosis.

Authors:  V V Yeremeev; I V Lyadova; B V Nikonenko; A S Apt; C Abou-Zeid; J Inwald; D B Young
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

6.  In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis.

Authors:  S Esin; G Batoni; G Saruhan-Direskeneli; R A Harris; J Grunewald; M Pardini; S B Svenson; M Campa; H Wigzell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.

Authors:  A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.

Authors:  S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Authors:  Y A Skeiky; P J Ovendale; S Jen; M R Alderson; D C Dillon; S Smith; C B Wilson; I M Orme; S G Reed; A Campos-Neto
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

10.  Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring.

Authors:  H Höhn; T Reichert; C Neukirch; H Pilch; M J Maeurer
Journal:  Int J Mol Med       Date:  1999-02       Impact factor: 4.101

View more
  6 in total

1.  Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Authors:  Peter A Sieling; Preston J Hill; Karen M Dobos; Kerry Brookman; Andrew M Kuhlman; Mario Fabri; Stephan R Krutzik; Thomas H Rea; Darragh G Heaslip; John T Belisle; Robert L Modlin
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

2.  High content cellular immune profiling reveals differences between rhesus monkeys and men.

Authors:  Isabelle Magalhaes; Nalini K Vudattu; Raija K Ahmed; Sharon Kühlmann-Berenzon; Yen Ngo; Donata R Sizemore; Lena Wehlin; Frank Weichold; Jan Andersson; Yasir A W Skeiky; Jerry Sadoff; Hans Gaines; Rigmor Thorstensson; Mats Spångberg; Markus J Maeurer
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

Review 3.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 4.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

5.  Immunoreactivity of the Mycobacterium avium subsp. paratuberculosis 19-kDa lipoprotein.

Authors:  Jason F J Huntley; Judith R Stabel; John P Bannantine
Journal:  BMC Microbiol       Date:  2005-01-21       Impact factor: 3.605

6.  Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.

Authors:  Federico Serana; Alessandra Sottini; Luigi Caimi; Belinda Palermo; Pier Giorgio Natali; Paola Nisticò; Luisa Imberti
Journal:  J Transl Med       Date:  2009-03-24       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.